Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome.

Background And Aims: Compiling evidence has emerged for the relevance of flow cytometric assessment as a valuable part of the diagnostic work-up of myelodysplastic syndrome (MDS). This study aimed at evaluating the implementation of a simple flow cytometric scoring system (FCSS), the Ogata score, in a routine diagnostic laboratory.

Methods: A total of 35 patient samples with a clinical suspicion of MDS were retrospectively assessed using the FCSS.